This is the 3rd workshop organized in the context of the European High Level Nuclear Round Table on Medical Applications, Research Infrastructures and Competences. The workshop aims to highlight the role of infrastructures and innovation in enabling breakthroughs in nuclear science for health applications.
How to register
Should you be interested in participating, please contact the meeting assistants for further information and details on the registration procedure, indicating whether you have a preference to attend on-site in Karlsruhe or remotely via Webex.
- medical research | cancer
- Wednesday 22 November 2023, 09:30 - 17:45 (CET)
- Karlsruhe, Germany
Programme
- 22 Nov 2023, 08:00 - 09:30 (CET)Arrival at the Joint Research Centre & coffee
- 09:30 - 10:00 (CET)Welcome remarks (Chair: Ulla Engelmann, Dir JRC.G)
Commissioner-designate (t.b.c.)
Bernard Magenhann (DDG JRC)
Jose Manuel Perez (Spanish Presidency, CIEMAT)
- 10:00 - 11:45 (CET)Topical session 1 – Landscape, challenges for medical radionuclide supply and research in the EU (Chair: Remigiusz Baranczyk, ESA)
10:00–10:15 Racing against time: the radiopharmaceutical supply chain (Paola Erba, European Association for Nuclear Medicine)
10:15–10:30 Commission action on medical isotopes – the SAMIRA Action Plan (Jan Panek, DG ENER)
10:30–10:45 Monitoring of irradiation capacities and supply of medical radionuclides (Bernard Ponsard, Nuclear Medicine Europe)
10:45–11:00 Ongoing initiatives to secure supply of medicines in the EU and to prevent shortages of medicinal products (Maria Alcaraz, EMA)
11:00–11:15 Q&A with all speakers
11:15 - 11:45 Coffee break
- 11:45 - 13:00 (CET)Topical session 2 – The industrial and innovative nuclear infrastructure landscape for medical radionuclide research and production
Chair: Alfred Morgenstern (JRC.G.II.6)
11:45–12:00 The present and future reactor landscape in the Netherlands for the production of medical radionuclides (Ronald Schram, NRG)
12:00–12:15 The BR2 reactor and the future MYRRHA facility – The role of Belgium for medical radionuclide production (Hamid Abderrahim, SCK-CEN)
12:15–12:30 The Jules Horowitz Reactor in the French landscape of medical radionuclides (David Emond, JHR)
12:30-12:45 Industrial infrastructure for the production of medical radionuclides (Harrie Buurlage, SHINE Medical)
12:45-13:00 Q&A with all speakers
- 13:00 - 14:00 (CET)Lunch break
- 14:00 - 16:00 (CET)Topical session 3 – Research and development in Europe on medical radionuclides Chair: Domenico Rossetti di Valdalbero (DG RTD)
14:00-14:15 PRISMAP, towards a sustainable European medical radionuclides programme (Thierry Stora, CERN)
14:15-14:30 Strengthening the European chain of supply for next-generation medical radionuclides (Renata Mikołajczak, Polatom)
14:30-14:45 Highlights from JRC research on medical radionuclides (Alban Kellerbauer, JRC.G.II.6)
14:45-15:00 R&D on Radium-226 for Actinium-225 production (Sven van den Berghe, Pantera)
15:00-15:15 Novel alpha- and Auger-emitting radionuclides for medical applications (Bertrand Morel, Orano)
15:15-15:30 Q&A with all speakers
15:30 -16:00 Coffee break
- 16:00 - 17:30 (CET)Break-out rooms / Survey on line / Discussion – Synergies to keep the EU at the forefront of R&I to secure radionuclide supply
Chairs: Margarida Goulart (HoU JRC.02) and Rachel Eloirdi (HoU JRC.G.II.6)
- Breakout room 1 (chaired by JRC)
- Breakout room 2 (chaired by OECD/NEA)
- Breakout room 3 (Chaired by DG ENER)
- 17:30 - 17:45 (CET)Wrap-up and closing remarks
Outlook: Alberto Fernandez Fernandez (Belgian Presidency 1st sem. 2024)
Closing remarks: Bernard Magenhann (DDG JRC)
Practical information
- When
- Wednesday 22 November 2023, 09:30 - 17:45 (CET)
- Where
- Joint Research CentreKarlsruhe, Germany
- Languages
- English
Description
This workshop will highlight the role of infrastructures and innovation in enabling breakthroughs in nuclear science for health applications. It will explore challenges in R&D for nuclear medicine and its translation into the market. Novel production routes will be presented along with an overview of existing and new nuclear infrastructures. The sustainable development and supply of radiopharmaceuticals will be a key focus to maintain the EU’s long-term leadership in medical radionuclide supply.
The workshop will be held as a hybrid event and can also be followed via Webex.
Attendance
Please note that for the attendance on site only a limited number of seats is available and registrations will be processed on a first come, first served basis.
Attending the workshop is free of charge, but no reimbursement for travel and hotel costs will be granted. The deadline for registration is 25 October 2023.
